{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:20:39Z","timestamp":1783542039212,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017619","name":"Northwest Minzu University","doi-asserted-by":"publisher","award":["31920240080"],"award-info":[{"award-number":["31920240080"]}],"id":[{"id":"10.13039\/501100017619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["23ZDFA003"],"award-info":[{"award-number":["23ZDFA003"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2022-sp09"],"award-info":[{"award-number":["lzujbky-2022-sp09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109337","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T23:14:39Z","timestamp":1765062879000},"page":"109337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of potent indole-2-one-based BRD4 PROTACs for the treatment of acute myeloid leukemia"],"prefix":"10.1016","volume":"168","author":[{"given":"Zhao-Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengya","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2025.109337_bb0005","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/cancers15061658","article-title":"Progress toward better treatment of therapy-related AML","volume":"15","author":"Kotsiafti","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.bioorg.2025.109337_bb0010","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood.V118.21.3484.3484","article-title":"Small-molecule inhibition of BRD4 is a novel promising approach to therapeutically target leukemia stem cells in AML","volume":"118","author":"Herrmann","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109337_bb0015","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.apsb.2024.12.037","article-title":"BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109337_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117152","article-title":"Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors","volume":"78","author":"Xu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116843","article-title":"Discovery of bi-magnolignan as a novel BRD4 inhibitor inducing apoptosis and DNA damage for cancer therapy","volume":"235","author":"Huang","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109337_bb0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109337_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/biolre\/ioaa043","article-title":"Metabolism of JQ1, an inhibitor of bromodomain and extra terminal bromodomain proteins, in human and mouse liver microsomes","volume":"103","author":"Li","year":"2020","journal-title":"Biol. Reprod."},{"issue":"49","key":"10.1016\/j.bioorg.2025.109337_bb0040","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109337_bb0045","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1158\/0008-5472.CAN-16-1793","article-title":"Preclinical characterization of BET family bromodomain inhibitor ABBV-075 suggests combination therapeutic strategies","volume":"77","author":"Bui","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109337_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106117","article-title":"Design, synthesis and biological evaluation of coumarin derivatives as potential BRD4 inhibitors","volume":"128","author":"Cui","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"6241","key":"10.1016\/j.bioorg.2025.109337_bb0055","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109337_bb0060","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1021\/acs.jmedchem.3c00520","article-title":"Precise conformational control yielding highly potent and exceptionally selective BRD4 degraders with strong antitumor activity","volume":"66","author":"Hu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109337_bb0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109337_bb0070","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/ange.201914396","article-title":"Structure-based design of a macrocyclic PROTAC","volume":"132","author":"Testa","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2025.109337_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112780","article-title":"Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors","volume":"208","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117752","article-title":"Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors","volume":"106","author":"Qiao","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114821","article-title":"Discovery of novel VEGFR-2-PROTAC degraders based on the localization of lysine residues via recruiting VHL for the treatment of gastric cancer","volume":"244","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105238","article-title":"Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4","volume":"115","author":"Xiang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115924","article-title":"Discovery of (R)-4-(8-methoxy-2-methyl-1-(1-phenylethy)-1H-imidazo [4, 5-c] quinnolin-7-yl)-3, 5-dimethylisoxazole as a potent and selective BET inhibitor for treatment of acute myeloid leukemia (AML) guided by FEP calculation","volume":"263","author":"Yu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109337_bb0100","doi-asserted-by":"crossref","first-page":"18082","DOI":"10.1021\/acs.jmedchem.1c01496","article-title":"Amide-to-ester substitution as a strategy for optimizing PROTAC permeability and cellular activity","volume":"64","author":"Klein","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104901","article-title":"Design and linkage optimization of ursane-thalidomide-based PROTACs and identiffcation of their targeted-degradation properties to MDM2 protein","volume":"111","author":"Qi","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115857","article-title":"Discovery of highly potent and selective KRASG12C degraders by VHL-recruiting PROTACs for the treatment of tumors with KRASG12C-mutation","volume":"261","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109337_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107943","article-title":"Discovery of potent hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) degraders by proteolysis targeting chimera (PROTAC)","volume":"153","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109337_bb0120","article-title":"Discovery of norbornene as a novel hydrophobic tag applied in protein degradation","volume":"62","author":"Xie","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109337_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chembiol.2019.11.006","article-title":"Degradation of polycomb repressive complex 2 with an EED-targeted bivalent chemical degrader","volume":"27","author":"Potjewyd","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109337_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10822-025-00630-3","article-title":"Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: a case study on kinase degraders","volume":"39","author":"Nandy","year":"2025","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2025.109337_bb0135","article-title":"Computer-aided drug design of some KRAS G12C inhibitors: targeting the covalent and allosteric binding site for cancer therapy","volume":"32","author":"Ogunlana","year":"2022","journal-title":"Inform. Med. Unlocked."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109337_bb0140","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1073\/pnas.1919507117","article-title":"MYC protein stability is negatively regulated by BRD4","volume":"117","author":"Devaiah","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109337_bb0145","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41422-021-00533-6","article-title":"Merging PROTAC and molecular glue for degrading BTK and GSPT1 proteins concurrently","volume":"31","author":"Yang","year":"2021","journal-title":"Cell Res."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109337_bb0150","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1021\/acs.jmedchem.1c00517","article-title":"Discovery of a novel BCL-XL PROTAC degrader with enhanced BCL-2 inhibition","volume":"64","author":"Pal","year":"2021","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109337_bb0155","doi-asserted-by":"crossref","first-page":"15340","DOI":"10.1021\/acs.jmedchem.3c01400","article-title":"Discovery of selective and potent macrocyclic CDK9 inhibitors for the treatment of osimertinib-resistant non-small-cell lung cancer","volume":"66","author":"Wu","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:32:58Z","timestamp":1783539178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S0045206825012179"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109337","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potent indole-2-one-based BRD4 PROTACs for the treatment of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109337"}}